Association of IGF-I levels with muscle strength and mobility in older women

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 9, 2001, Pages 4139-4146

  Cappola, Anne R ^a,d   Bandeen Roche, Karen ^b   Wand, Gary S ^a   Volpato, Stefano ^c   Fried, Linda P ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

AGED; AGING; ARTICLE; BLOOD LEVEL; BODY COMPOSITION; FEMALE; HUMAN; JOINT MOBILITY; LEAN BODY WEIGHT; LIVER FUNCTION; MAJOR CLINICAL STUDY; MUSCLE STRENGTH; NUTRITIONAL STATUS; OUTCOMES RESEARCH; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; POPULATION RESEARCH; PRIORITY JOURNAL; SELF REPORT; TASK PERFORMANCE; WALKING;

EID: 0034853487     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.9.7868     Document Type: Article

References (30)

1. Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin
2. Insulin-like growth factor 1 and functional status in healthy older men
3. Epidemiology of insulin-like growth factor-1 in elderly men and women. The Rancho Bernardo Study
4. Association of insulin-like growth factor-I with body composition, weight history, and past health behaviors in the very old: The Framingham Heart Study
5. Serum levels of insulin-like growth factor-1 are related to age and not to body composition in healthy women and men
6. Relationship between age-associated endocrine deficiencies and muscle function in elderly women: A cross-sectional study
7. Human growth hormone and human aging
8. Physical activity and dehydroepiandrosterone sulphate, insulin-like growth factor I and testosterone in healthy active elderly people
9. Responses of total and free insulin-like growth factor-I and insulin-like growth factor binding protein-3 after resistance exercise and training in elderly subjects
10. Influence of physical activity on insulin-like growth factor-I in healthy younger and older men
11. Insulin-like growth factor I as an indicator of protein-energy undernutrition among metabolically stable hospitalized elderly
12. Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults
13. Lack of an association between insulin-like growth factor-I and body composition, muscle strength, physical performance or self-reported mobility among older persons with functional limitations
14. Serum free and total insulin-like growth factor-I, insulin-like growth factor binding protein-1 and insulin-like growth factor binding protein-3 Levels in healthy elderly individuals. Relation to self-reported quality of health and disability
15. Preclinical mobility disability predicts incident mobility disability in older women
16. A questionnaire for the assessment of leisure time physical activities
17. Anthropometric measurement of muscle mass: Revised equations for calculating bone-free arm muscle area
18. Association of muscle strength with maximum walking speed in disabled older women
19. Splines in statistics
20. Evidence for a non-linear relationship between leg strength and gait speed
21. Appendix A: Sample design, weighting, and estimation procedures, and computation of sampling errors
22. Effects of human GH in men over 60 yr old
23. The effects of recombinant human insulin-like growth factor-I and GH on body composition in elderly women
24. GH increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 yr old
25. GH replacement in healthy older men improves body composition but not functional ability
26. Diagnostic and therapeutic uses of GH-releasing substances in adult and elderly subjects